Update on Patents Offered for Sale and Licensing, Grant Applications

International Patent Offering

NanoLogix is pleased to provide this update on the ongoing work on the sale and/or licensing of the international issued FlatPack patents, and filed and in-process applications to the National Institutes of Health, The National Science Foundation and BARDA

We have had interest in the technology from companies in France, Spain, Turkey, Serbia, South Africa, and China. The interest varies from licensing arrangements, purchase, and through direct representation of our products.

​The Company is currently in the process of raising $30,000 for the April payment of the international annuities for the issued FlatPack patents and pending applications in the following countries:

​Issued: China, New Zealand, Chile, Mexico, South Africa, UK, Germany, Sweden, France, Spain, Italy, Switzerland, Serbia, Croatia, Turkey, Denmark, Ireland, Poland, and the Netherlands.

​Pending: Brazil, Canada

Grant Applications

One grant application has been filed with the National Institutes of Health (NIH) and two additional are planned with The National Science Foundation (NSF) and the Biomedical Advance Research and Development Authority (BARDA). Two of the applications are for funding for a pre-test for use with the N-Assay modified ELISA diagnostic and the BARDA application is for the use of the N-Assay for diagnostics of bio-threat agents.

As stated with the previous update from November, while there is strong competition for the grants, we believe the N-Assay and what it offers will be attractive to the grant evaluators.